Blog
The Way Forward for Antibodies in Neuroscience
BlogAntibodies are an essential part of everyday neuroscience research. But recently, high-profile criticism has cast doubt on their reliability and reproducibility. We caught up with Bio-Techne’s Raymond Chan and Katherine Bradley to find out how providers are hoping to improve antibodies and make them fit for a more reproducible future in neuroscience.
Read More
Into the Cloud: How Pharmaceutical and Biotechnology Companies Can Balance Cybersecurity With Efficient Data Sharing
BlogThe pharmaceutical and biotechnology industry is the number one target for cybercriminals, according to recent survey. Unsurprisingly, data security is now top of the agenda for most companies in this sector. How can organizations balance robust cybersecurity with the need for efficient flow of information between colleagues and collaborators?
Read More
Colorectal Cancer Blood Test Driven by Immuno-transcriptomics
BlogBy studying gene expression modifications induced by the immune response, Novigenix has developed a blood test for colorectal cancer. This Q&A with Jan Groen, CEO, provides insights on the test, and on the field of study that could revolutionize cancer diagnosis.
Read More
Chewing on the Fat of Food Analysis and Beyond
BlogTo ensure safety and consistency of products within the food industry, continual analysis through the production process is essential. We spoke to Ian Olmsted, from CEM Corporation, about ORACLE, an innovative solution that enables analysts to measure fat in food and much more without the fuss of traditional techniques.
Read More
Anti-influenza Agents Inspired by Immunotherapy
BlogGiven the urgent need for compounds that can effectively prevent and treat influenza, San Diego-based Cidara Therapeutics are working to develop antiviral conjugates. We spoke to Les Tari, Senior VP of Research, to find out about their unique approach and lead candidate.
Read More
Seeing Is Believing – How Benchtop SEMs Are Changing the Imaging Landscape
BlogImaging techniques, such as scanning electron microscopy (SEM), have been instrumental in giving insights into the world beyond the naked eye. Traditional SEM instruments have provided us with unprecedented details, but can be complex to use, and require a large dedicated space. The dawn and advancement of compact and user-friendly benchtop SEMs are changing this picture. We spoke to Donna Guarrera, Assistant Division Director for SM at Jeol, about the Neoscope benchtop SEM.
Read More
Developing a Single-shot Vaccine Against Chikungunya
BlogChikungunya is a viral disease which can be transmitted via the bite of a mosquito infected with the chikungunya virus (CHIKV). Currently there is no preventative vaccine approved for use. We recently spoke with Thomas Lingelbach, CEO at Valneva to learn more about the development of the company's chikungunya vaccine candidate and the results of their recent Phase 1 clinical study.
Read More
ASMS Introduces… An Overview of What’s New for 2019
BlogThe 67th American Society for Mass Spectrometry (ASMS) Conference on Mass Spectrometry and Allied Topics is currently in full swing in Atlanta, Georgia. Bringing together over 6,500 scientists from across the globe, companies working in the mass spectrometry field also take this opportunity to share their latest developments and innovations. Here we will take a look at some of the release highlights for 2019.
Read More
DNA Methylation Analysis for Early Detection of Various Cancers
BlogWe recently spoke to Richard Brand, CFO and Dhruvajyoti Roy, Director of Technology from the Laboratory for Advanced Medicine (LAM) to learn more about how LAM is developing methylation-based tests for the early detection and intervention of cancer.
Read More
Why Should Antibodies Be Manufactured Recombinantly?
BlogGiven that bad antibodies are likely to blame for a significant proportion of the reproducibility crisis in science, any efforts to reduce batch-to-batch variability are more than welcome. One company with a plan to help in this area is “Absolute Antibody”, who believe that recombinant antibodies are the way forward. To learn more about making antibodies with recombinant technology, we spoke to Ian Wilkinson, PhD, Chief Scientific Officer.
Read More
